Page last updated: 2024-11-08

diethylnitrosamine and Compensatory Hyperinsulinemia

diethylnitrosamine has been researched along with Compensatory Hyperinsulinemia in 1 studies

Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.

Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazaki, T1
Shirakami, Y1
Kubota, M1
Ideta, T1
Kochi, T1
Sakai, H1
Tanaka, T1
Moriwaki, H1
Shimizu, M1

Other Studies

1 other study available for diethylnitrosamine and Compensatory Hyperinsulinemia

ArticleYear
Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
    Oncotarget, 2016, Mar-01, Volume: 7, Issue:9

    Topics: Alginates; Animals; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diethylnitrosa

2016